SCHEMBL7414151

SCHEMBL7414151

CSCCC(NC(=O)OC(C)(C)C)C(=O)Nc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 2/20 0.61
CTSK P43235 2/20 0.61
HDAC4 P56524 3/20 0.58
HDAC1 Q13547 3/20 0.58
HDAC8 Q9BY41 2/20 0.56
HDAC3 O15379 1/20 0.56
HDAC7 Q8WUI4 1/20 0.56
HDAC2 Q92769 1/20 0.56
HDAC10 Q969S8 1/20 0.56
HDAC11 Q96DB2 1/20 0.56
HDAC6 Q9UBN7 1/20 0.56
HDAC9 Q9UKV0 1/20 0.56
HDAC5 Q9UQL6 1/20 0.56
CA2 P00918 1/20 0.53
KLK5 Q9Y337 1/20 0.53
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 1/20 0.51
MAPT P10636 1/20 0.51
KLK7 P49862 1/20 0.51
BACE1 P56817 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7414154 1.00 CTSS (0.61) CTSSCTSKHDAC4HDAC1HDAC8
SCHEMBL23975809 1.00 CTSS (0.61) CTSSCTSKHDAC4HDAC1HDAC8
SCHEMBL24451416 0.89 HDAC8 (0.57) CTSSCTSKHDAC4HDAC1HDAC8
SCHEMBL21585118 0.89 CA2 (0.55) CTSSCTSKHDAC4HDAC1HDAC8
SCHEMBL6555098 0.88 CTSS (0.56) CTSSCTSKHDAC4HDAC1HDAC8
SCHEMBL31075491 0.88 CTSS (0.56) CTSSCTSKHDAC4HDAC1CA2
SCHEMBL6557192 0.88 CTSS (0.56) CTSSCTSKHDAC4HDAC1CA2
SCHEMBL5570008 0.88 KLK5 (0.56) CTSSCTSKHDAC8CA2KLK5
SCHEMBL5570005 0.88 KLK5 (0.56) CTSSCTSKHDAC8CA2KLK5
SCHEMBL21585117 0.87 CA2 (0.56) CTSSCTSKHDAC4HDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed
EP-0796245-B1 PROCESS FOR THE PREPARATION OF AMIDINO PHENYL PYRROLIDINE BETA-ALANINE UREA ANALOGS SEARLE & CO (US) 2000-07-26 EP disclosed
EP-0796245-A1 PROCESS FOR THE PREPARATION OF AMIDINO PHENYL PYRROLIDINE $g(b)-ALANINE UREA ANALOGS G.D. SEARLE & CO. (US) 1997-09-24 EP disclosed
US-5659063-A AMINE-BLOCKED METHIONINE ANALOG CYCLIZABLE TO A LACTAM IN NONVOLATILE OR NONTOXIC REAGENTS; ANTITHROMBOTIC AGENTS G. D. SEARLE & CO. (US) 1997-08-19 US disclosed
US-5610296-A CHEMICAL INTERMEDIATES OF ANTITHROMBOTICS G. D. SEARLE & CO. (US) 1997-03-11 US disclosed
US-5576447-A Process for the preparation of amidino phenyl pyrrolidine β-alanine urea analogs G. D. SEARLE & CO. (US) 1996-11-19 US disclosed
WO-1996017827-A1 PROCESS FOR THE PREPARATION OF AMIDINO PHENYL PYRROLIDINE β-ALANINE UREA ANALOGS G.D. SEARLE & CO. (US) 1996-06-13 WO disclosed
US-5484946-A CYCLIZATION AND DEHYDRATION A METHIONINE DERIVATIVE G. D. SEARLE & CO. (US) 1996-01-16 US disclosed